Related Experiment Video
Updated: Jul 6, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Altered lipid metabolism in human platelets after primary aggregation.
The Journal of Clinical Investigation
|February 1, 1973
Summary
Thrombin and poly-l-lysine disrupt how human platelets incorporate acetate, glycerol, and fatty acids into lipids. This suggests platelet aggregation involves defects in complex lipid assembly.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Platelets play a crucial role in hemostasis and thrombosis.
- Lipid metabolism is essential for platelet function and activation.
Purpose of the Study:
- To investigate the effects of thrombin and poly-l-lysine on human platelet lipid synthesis.
- To understand the relationship between platelet aggregation and lipid incorporation.
Main Methods:
- Washed human platelets were incubated with thrombin or poly-l-lysine.
- Incorporation of radiolabeled acetate, glycerol, and fatty acids (palmitic acid, oleic acid) into various lipid classes was measured.
Main Results:
- Both thrombin and poly-l-lysine reduced acetate incorporation into most lipid classes.
- Glycerol incorporation into complex lipids was impaired by both agents.
- Thrombin decreased palmitic acid incorporation into lecithin and triglycerides but increased oleic acid incorporation into lecithin.
Conclusions:
- Platelet aggregation induced by thrombin and poly-l-lysine is associated with altered lipid metabolism.
- These changes suggest a defect in the assembly of complex lipids during primary platelet aggregation.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.